BCLSI
Bain Capital Life Sciences Investors Portfolio holdings
AUM
$799M
This Quarter Return
-17.34%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$591M
AUM Growth
+$591M
(-12%)
Cap. Flow
+$107M
Cap. Flow
% of AUM
18.14%
Top 10 Holdings %
Top 10 Hldgs %
98.44%
Holding
11
New
1
Increased
2
Reduced
1
Closed
–
Top Buys
| 1 |
Arcutis Biotherapeutics
ARQT
|
$119M |
| 2 |
APTX
Aptinyx Inc. Common Stock
APTX
|
$7.2M |
| 3 |
Dynavax Technologies
DVAX
|
$983K |
Top Sells
| 1 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
$19.5M |
Sector Composition
| 1 | Healthcare | 85.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWTX
1
DELISTED
SpringWorks Therapeutics
SWTX
| $197M | 33.25% | 7,281,307 | – | – |
|
|
2
Arcutis Biotherapeutics
ARQT
$1.86B
| $119M | 20.05% | +3,979,292 | New | +$119M |
|
|
DRNA
3
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $75M | 12.68% | 4,080,237 | – | – |
|
|
CNST
4
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $69.3M | 11.71% | 2,203,529 -620,000 | -22% | -$19.5M |
|
|
5
Dynavax Technologies
DVAX
$1.19B
| $30.8M | 5.21% | 8,730,707 +278,472 | +3% | +$983K |
|
6
Replimune Group
REPL
$422M
| $28.3M | 4.79% | 2,838,968 | – | – |
|
7
Savara
SVRA
$567M
| $23M | 3.89% | 5,128,593 | – | – |
|
8
X4 Pharmaceuticals
XFOR
$84.3M
| $16.5M | 2.79% | 1,648,485 | – | – |
|
|
MRNS
9
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $12.1M | 2.04% | 5,942,735 | – | – |
|
|
APTX
10
DELISTED
Aptinyx Inc. Common Stock
APTX
| $12M | 2.03% | 5,558,425 +3,333,333 | +150% | +$7.2M |
|
11
Solid Biosciences
SLDB
$427M
| $9.25M | 1.56% | 3,871,164 | – | – |
|